HOME >> BIOLOGY >> NEWS
MITs smart surface switches properties reversibly

CAMBRIDGE, Mass.--MIT engineers and colleagues from the University of California are reporting a unique design of a smart surface that can reversibly switch properties in response to an external stimulus. The work paves the way for systems that could, for example, release or absorb cells and chemicals from surfaces on demand.

In the Jan. 17 issue of Science, the researchers describe an example of their new approach in which they engineered a surface that can change from water-attracting to water-repelling with the application of a weak electric field. Switch the electrical potential of that field from positive to negative and the surface reverts to its initial affinity for water.

The general technique, on which the group has filed for a patent, could also be applied to the dynamic control of other surface characteristics such as adhesion, friction and biocompatibility. We started with a fundamental system to prove that the overall concept of reversibly modifying a surface via conformational transitions works, said Thanh-Nga Tran, a graduate student in the Harvard-MIT Division of Health Sciences and Technology (HST) and the Department of Chemical Engineering.

This opens the door to a variety of applications, including novel drug-delivery systems and smart templates for the bioseparation of one molecule from another, said Robert Langer, MITs Germeshausen Professor of Chemical and Biomedical Engineering and leader of the work. Langer has appointments in chemical engineering, HST and MITs Biological Engineering Division.

This is the first time to our knowledge that anyone has created a truly reversible switch of a surfaces property exploiting monomolecular layers, said Joerg Lahann, a Postdoctoral Associate in CE. As a result, we believe this study lays the fundamental groundwork for a new paradigm in surface engineering that may be of considerable significance in materials science, biology, and medicine.

In addition to L
'"/>

Contact: Elizabeth Thomson
thomson@mit.edu
617-258-5402
Massachusetts Institute of Technology
16-Jan-2003


Page: 1 2 3

Related biology news :

1. Study of flu patients reveals virus outsmarting key drug
2. Muscles are smarter than you think
3. Purdue scientists finding ways to outsmart crop-damaging bugs
4. With natures help, a better vision system for smart weapons
5. UCSD researchers fabricate tiny smart dust particles
6. Scientists at the Scripps Research Institute design gene-tipped tumor regressor smartbombs
7. Researchers developing technology to outsmart metastasized cancers
8. How did we get so smart? Study sheds light on evolution of the brain
9. Pharmaceutical smart bomb targets cancer cells
10. Female birds choose best singers to have smarter offspring
11. Prosthetic limb to be controlled by microchip: Agreement signed to create smart leg

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: MITs smart surface switches properties reversibly

(Date:7/23/2014)... The drought that has the entire country in its grip ... may also be responsible for the proliferation of a heat-loving ... rivers and hot springs, which the drought has made warmer ... died of an infection caused by this parasite after swimming ... the nose of an individual and travels to the brain. ...
(Date:7/23/2014)... available in German . ... cells, drive metabolic processes and transmit signals. To perform ... Scientists at the Max Planck Institute for Developmental Biology ... constructed of similar amino acid chains even when their ... that exist today arose from common precursors. Presumably, in ...
(Date:7/23/2014)... 2014 BioCatch, the global leader ... it has been named in Gartner,s Market Guide for ... Gartner,s well-known Magic Quadrant for Web Fraud Detection. ... of several vendors to deliver passive biometric analysis and ... standard feature of at least 30% of one-stop fraud ...
Breaking Biology News(10 mins):Diseases of another kind 2Protein evolution follows a modular principle 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 3
(Date:7/23/2014)... July 23, 2014 ... of Trendlines Agtech , announced it has ... Israel,s leading agricultural thermoplastics applications companies. ... Valentis,s technology combines nanocrystalline cellulose (NCC), a biodegradable, ... additional nanoparticles to produce highly improved polymeric films. ...
(Date:7/23/2014)... BRUSSELS , July 23, 2014 regulated ... its research and development pipeline with positive topline ... brivaracetam . This study was designed to evaluate ... (100 and 200 mg/day, without titration) compared to ... patients with partial-onset seizures, not fully controlled despite ...
(Date:7/23/2014)... Calif. , July 23, 2014  Sofinnova Ventures, ... firm, today announced the closing of Sofinnova Venture Partners ... and in excess of the initial fund target of ... entrepreneurs build successful biotechnology companies. Consistent with recent funds, ... promising later stage clinical programs, along with select investments ...
(Date:7/23/2014)... 23, 2014 OncLive® is pleased ... has joined its Strategic Alliance Partnership program. ... program, UNC Lineberger will have the opportunity to ... of its cutting-edge research initiatives, community-directed cancer prevention ... will work with OncLive to educate their peers ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3
Cached News: